Joseph Italiano: Exploring the Intersection of Megakaryocyte Biology and Chronic Kidney Disease
Joseph Italiano, Associate Professor of Medicine of Harvard University and Co-founder of Platelet BioGenesis, shared a post on LinkedIn about recent article he and his colleagues co-authored:
“I’m excited to share our latest study, published in Blood Advances and led by Estelle Carminita, exploring the intersection of megakaryocyte biology and chronic kidney disease.
In this work, we demonstrate that chronic kidney disease reprograms megakaryocytes, driving the production of dysfunctional platelets.
We’re deeply grateful to our outstanding collaborators whose expertise and dedication made this work possible.”
Title: Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming
Authors: Estelle Carminita, Virginia Camacho, Siobhan Branfield, Ethan Walsey, Maria N. Barrachina, Dylan N. Tabang, Dong H. Lee, Isabelle C. Becker, Sergey V. Brodsky, Samer M. Issa, Nicolas Gendron, Sarah Machado, Alisa S. Wolberg, Hanno Steen, Bryce Kerlin, Kellie R. Machlus, Abolfazl Zarjou, Joseph E. Italiano
Read the Full Article on Blood Advances.

Stay updated with Hemostasis Today.
-
Mar 6, 2026, 09:13Louise St. Germain Bannon: Advancing Thrombosis and Hemostasis Through a Global Community
-
Mar 6, 2026, 09:06Kathleen Freson: Protein C Deficiency as a Genetic Modifier of Severe Haemophilia A
-
Mar 5, 2026, 17:48Estelle Carminita։ What If the Origin of Platelet Dysfunction Starts in the Bone Marrow
-
Mar 5, 2026, 17:43Pierre Sabouret: The Best Antithrombotic Strategy in Patients with Atherosclerotic Stroke and AF
-
Mar 5, 2026, 17:37John Abraham։ The Role of Diagnostic Splenectomy in Unexplained Splenomegaly
-
Mar 5, 2026, 17:31Fayad Al-Haimus: Key Themes from the New 2026 AHA/ACC Guideline for Acute PE
-
Mar 5, 2026, 16:56From Chronic Pain with Every Step to Exercising Every Day – EHC
-
Mar 5, 2026, 15:51Samer Al Hadidi: Cytopenias and Infection Risk With BCMA-Directed Bispecific Antibodies
-
Mar 5, 2026, 15:35Ney Carter Borges: Cholesterol-Inflammation Fusion in Atherosclerosis